Media Articles Related to Rhinocort (Budesonide)
Allergic Rhinitis: 3 Years of Immunotherapy Needed
Source: Medscape Allergy & Clinical Immunology Headlines [2017.02.14]
When treatment was shortened from 3 years to 2, sublingual immunotherapy proved no better than placebo for patients with grass pollen allergy.
Medscape Medical News
Hay Fever (Allergic Rhinitis)
Source: MedicineNet Allergic Cascade Specialty [2016.10.07]
Title: Hay Fever (Allergic Rhinitis)
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 10/7/2016 12:00:00 AM
Published Studies Related to Rhinocort (Budesonide)
Budesonide foam induces remission in patients with mild to moderate ulcerative
proctitis and ulcerative proctosigmoiditis. 
remission in patients with ulcerative proctitis or ulcerative proctosigmoiditis... CONCLUSIONS: Budesonide rectal foam was well tolerated and more efficacious than
Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative
colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies. 
budesonide MMX in patients with mild-to-moderate active UC... CONCLUSION: This pooled analysis showed that budesonide MMX 9 mg is efficacious,
Effects of nebulized high-dose budesonide on moderate-to-severe acute
exacerbation of asthma in children: a randomized, double-blind,
placebo-controlled study. 
exacerbation of asthma... CONCLUSION: On the basis of nebulized short-acting bronchodilators, addition of
Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler(R) in Japanese Patients with Asthma: A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study. [2012.01.01]
Background: The use of budesonide/formoterol as both maintenance and reliever therapy in asthma is recommended in many countries; however, there are limited data available for the Asian patient population. Objective: This study aimed to evaluate the short-term safety and tolerability of a fixed high-dose combination of the inhaled corticosteroid budesonide and the long-acting beta(2)-adrenoceptor agonist formoterol with that of the beta(2)-agonist terbutaline for acute symptom relief in Japanese adults with persistent asthma who were already receiving a combination of budesonide/formoterol maintenance therapy...
Abatacept for Crohn's disease and ulcerative colitis. 
modulator, in Crohn's disease (CD) and ulcerative colitis (UC) is unknown... CONCLUSIONS: The studies showed that abatacept is not efficacious for the
Clinical Trials Related to Rhinocort (Budesonide)
Assess the Efficacy and Safety of Rhinocort Aqua [Completed]
The purpose of this study is to compare Rhinocort with placebo in pediatric subjects aged
2-5 years with allergic rhinitis to study effects on nasal symptoms such as sneezing, runny
and stuffy noses.
Rhinocort Aqua Versus Placebo and Fluticasone Propionate [Completed]
The purpose of this study is to compare once daily treatment with Rhinocort against placebo
and Fluticasone Propionate at reliving the nasal symptoms of seasonal allergic rhinitis.
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer [Completed]
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing,
or coming back. The use of budesonide may keep lung cancer from forming in patients with
PURPOSE: This randomized phase II trial is studying how well inhalation budesonide works in
treating patients with lung nodules who are at high risk of lung cancer.
Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide [Completed]
Glucocorticosteroids recently have been shown to have non-genomic actions that are plasma
membrane-mediated and do not require gene transcription and translation. One of these
non-genomic effects is the inhibition of adrenergic agonist transport into airway vascular
smooth muscle cells with an increase of adrenergic agonist concentrations at adrenergic
receptor sites and enhance the physiological effects of endogenous adrenergic agonists (e. g.
locally released norepinephrine from noradrenergic neurons) or exogenous adrenergic agonists
(e. g. inhaled beta-adrenergic agonists).
Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR [Completed]
The primary objective of this study was to compare the relative efficacy of Budesonide
administered via Captisol-Enabled Budesonide nasal solution and Rhinocort Aqua in patients
with seasonal allergic rhinitis (SAR) exposed to controlled ragweed pollen using an EEC
Reports of Suspected Rhinocort (Budesonide) Side Effects
Drug Dose Omission (66),
Intentional Drug Misuse (28),
Gastrooesophageal Reflux Disease (27),
OFF Label USE (25),
Drug Ineffective (22),
Nasal Congestion (21), more >>